MarketCap
Facebook
X
TelegramQuarterly report 2026-Q1
added 05-16-2026
Butterfly Network Retained Earnings 2011-2026 | BFLY
Retained earnings — this is the portion of a company’s net profit that has not been distributed to shareholders as dividends but remains at the company’s disposal for future use. It is also referred to as retained income or accumulated earnings.Possible uses include
- reinvestment in development (R&D, equipment, marketing)
- debt repayment
- acquisition of other companies
- creation of reserves for the future
A high level of retained earnings indicates that the company is in a growth phase, accumulating capital and prioritizing reinvestment over dividend payouts. Conversely, low or negative retained earnings may suggest either a generous dividend policy, in which all profits are distributed to shareholders, or ongoing losses that reduce the overall financial result.
The presence of retained earnings does not indicate that the company has available cash — it is solely an accounting figure reflecting the accumulated portion of net profit remaining after dividends have been paid. Therefore, it is important for investors to analyze not only the amount of retained earnings, but also how effectively it is used to develop the business, reduce debt, or build financial stability.
Annual Retained Earnings Butterfly Network
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -879 M | -802 M | -730 M | -596 M | -427 M | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| -427 M | -879 M | -687 M |
Quarterly Retained Earnings Butterfly Network
| 2026-Q1 | 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -892 M | -864 M | -830 M | -816 M | -784 M | -767 M | -751 M | -686 M | -658 M | -629 M | -596 M | -562 M | - | -472 M | -427 M | -412 M | -398 M | -395 M | -395 M | -395 M | -395 M | -395 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| -395 M | -892 M | -596 M |
Retained Earnings of other stocks in the Medical devices industry
| Issuer | Retained Earnings | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
GenMark Diagnostics, Inc.
GNMK
|
-533 M | - | - | $ 1.77 B |  USA |
 |
Avinger
AVGR
|
-421 M | - | -20.74 % | $ 369 K | USA |
 |
Axonics Modulation Technologies
AXNX
|
-380 M | - | - | $ 3.31 B | USA |
 |
Eargo
EAR
|
-514 M | - | - | $ 10.2 M | USA |
 |
Allied Healthcare Products
AHPI
|
-15.7 M | - | 3.58 % | $ 2.21 M | USA |
 |
Obalon Therapeutics, Inc.
OBLN
|
-185 M | - | -5.86 % | $ 30.6 M | USA |
 |
ClearPoint Neuro
CLPT
|
-217 M | $ 12.42 | 1.47 % | $ 352 M | USA |
 |
Apollo Endosurgery
APEN
|
-337 M | - | - | $ 475 M | USA |
 |
Alphatec Holdings
ATEC
|
-1.42 B | $ 7.87 | -0.25 % | $ 1.18 B | USA |
 |
Aziyo Biologics
AZYO
|
-176 M | - | 1.37 % | $ 20.5 M | USA |
 |
EDAP TMS S.A.
EDAP
|
-82.6 M | $ 4.38 | 4.29 % | $ 164 M |  France |
 |
BioSig Technologies
BSGM
|
-718 M | - | 37.08 % | $ 85.7 M | USA |
 |
BIOLASE
BIOL
|
-317 M | - | -13.19 % | $ 166 K | USA |
 |
Conformis
CFMS
|
-581 M | - | - | $ 16.4 M | USA |
 |
IRIDEX Corporation
IRIX
|
-92.4 M | $ 1.02 | -0.97 % | $ 17.3 M | USA |
 |
Cardiovascular Systems
CSII
|
-424 M | - | 0.15 % | $ 844 M | USA |
 |
Helius Medical Technologies
HSDT
|
-213 M | $ 1.91 | -6.62 % | $ 42.1 M | USA |
 |
CryoLife, Inc.
CRY
|
20 M | - | -4.14 % | $ 702 M | USA |
 |
Cytosorbents Corporation
CTSO
|
-312 M | $ 0.49 | -1.17 % | $ 30.5 M | USA |
 |
OrthoPediatrics Corp.
KIDS
|
-275 M | $ 17.15 | -3.71 % | $ 402 M | USA |
 |
LENSAR
LNSR
|
-178 M | $ 5.85 | -2.5 % | $ 70 M | USA |
 |
Delcath Systems
DCTH
|
-529 M | $ 10.9 | -0.44 % | $ 390 M | USA |
 |
Soliton, Inc.
SOLY
|
-70.6 M | - | -1.42 % | $ 435 M | USA |
 |
Pulmonx Corporation
LUNG
|
-522 M | $ 1.65 | -2.08 % | $ 67.1 M | USA |
 |
Hancock Jaffe Laboratories, Inc.
HJLI
|
-56.2 M | - | -1.98 % | $ 98.3 M | USA |
 |
LivaNova PLC
LIVN
|
-1.15 B | $ 73.65 | 0.84 % | $ 4.02 B |  Britain |
 |
Itamar Medical Ltd.
ITMR
|
-119 M | - | 0.03 % | $ 1.58 B |  Israel |
 |
Misonix, Inc.
MSON
|
-39.3 M | - | - | $ 462 M | USA |
 |
Myomo
MYO
|
-119 M | $ 1.09 | - | $ 45.6 M | USA |
 |
Neovasc
NVCN
|
-420 M | - | - | $ 111 M |  Canada |
 |
Dynatronics Corporation
DYNT
|
-40.5 M | - | 14.99 % | $ 929 K | USA |
 |
MiMedx Group
MDXG
|
-42.7 M | $ 3.72 | 1.36 % | $ 550 M | USA |
 |
Electromed
ELMD
|
21.2 M | $ 38.47 | -2.09 % | $ 325 M | USA |
 |
Orthofix Medical
OFIX
|
-368 M | $ 9.37 | -1.26 % | $ 371 M |  Curacao |
 |
Intersect ENT, Inc.
XENT
|
-303 M | - | - | $ 955 M | USA |
 |
Second Sight Medical Products
EYES
|
-149 M | - | -0.97 % | $ 54.4 M | USA |
 |
Profound Medical Corp.
PROF
|
-288 M | $ 6.85 | -0.8 % | $ 207 M | Canada |
 |
GBS
GBS
|
-62.5 M | - | -0.57 % | $ 7.12 M | USA |
 |
Globus Medical
GMED
|
1.39 B | $ 81.72 | -0.9 % | $ 11 B | USA |
 |
Insulet Corporation
PODD
|
287 M | $ 142.42 | -0.16 % | $ 10 B | USA |
 |
Sintx Technologies
SINT
|
-292 M | $ 2.23 | 1.14 % | $ 6.18 M | USA |
 |
CONMED Corporation
CNMD
|
589 M | $ 35.7 | 0.79 % | $ 1.11 B | USA |
 |
Inspire Medical Systems
INSP
|
-146 M | $ 42.07 | -2.39 % | $ 1.24 B | USA |
 |
Integer Holdings Corporation
ITGR
|
994 M | $ 90.31 | 0.31 % | $ 3.14 B | USA |
 |
Invacare Corporation
IVC
|
-78.4 M | - | - | $ 24.7 M | USA |
 |
Edwards Lifesciences Corporation
EW
|
14.2 B | $ 86.15 | 0.23 % | $ 50.4 B | USA |
 |
TransMedics Group
TMDX
|
-278 M | $ 67.33 | -0.73 % | $ 2.29 B | USA |